NUGALVIQ Trademark

Trademark Overview


On Monday, October 7, 2024, a trademark application was filed for NUGALVIQ with the United States Patent and Trademark Office. The USPTO has given the NUGALVIQ trademark a serial number of 98787898. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, June 10, 2025. This trademark is owned by Applied Therapeutics, Inc.. The NUGALVIQ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for treatment of rare orphan diseases; Pharmaceutical preparations for treatment of diseases that impact sugar and glucose metabolism; Pharmaceutical preparations for inhibiting aldose reductase; Pharmaceutical preparations for treatment of galactosemia, sorbitol dehydrogenase (SORD) deficiency and PMM2-congenital disorder of glycosylation (PMM2-CDG)
nugalviq

General Information


Serial Number98787898
Word MarkNUGALVIQ
Filing DateMonday, October 7, 2024
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, June 10, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 15, 2025

Trademark Statements


Goods and ServicesPharmaceutical preparations for treatment of rare orphan diseases; Pharmaceutical preparations for treatment of diseases that impact sugar and glucose metabolism; Pharmaceutical preparations for inhibiting aldose reductase; Pharmaceutical preparations for treatment of galactosemia, sorbitol dehydrogenase (SORD) deficiency and PMM2-congenital disorder of glycosylation (PMM2-CDG)

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, October 7, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameApplied Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Party NameApplied Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events


Event DateEvent Description
Monday, October 7, 2024NEW APPLICATION ENTERED
Thursday, March 20, 2025ASSIGNED TO EXAMINER
Wednesday, April 9, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 15, 2025PUBLISHED FOR OPPOSITION
Tuesday, April 15, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 10, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, March 20, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, October 7, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED